Metallomix, Inc

MIAMI, FL · Founded 2021 · CIK 0001894153 · Biotech · Private

Small-molecule therapeutics targeting metalloprotein pathways for oncology

metallomix.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$2.1M
4 Form D · Nov 2025
11 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$100,000
Private capital raisedForm D · SEC$300,000
Private capital raisedForm D · SEC$534,200
Private capital raisedForm D · SEC$1,158,060
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1713Lila Sciences——
1714ARC Biotechnology LLC——
1715ARMAGEN TECHNOLOGIES, INC.——
1716Metallomix, Inc—$2.1M
1717Mission Therapeutics——
1718Curve Therapeutics——
1719Peroxitech LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 3 related persons
  • Sergey GurinDirector · Executive Officer
  • Sergei PetukhovDirector · Executive Officer
  • Max TemnikExecutive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.